Projects per year
Search results
-
Active
Oct 2022 R01 - Novel gene delivery - Resubmission - 1
Chen, S.-H. (PI)
6/1/24 → 5/31/29
Project: Federal Funding Agencies
-
Engineered CAR-T cells for the treatment of diffuse large B cell lymphoma
Chen, S.-H. (PI)
9/1/23 → 8/31/27
Project: Federal Funding Agencies
-
Targeting the immunosuppressive microenvironment of prostate cancer to enhance therapeutic efficacy of the immune checkpoint inhibitors
Chen, S.-H. (PI)
6/1/23 → 5/31/26
Project: Federal Funding Agencies
-
A Phase II Clinical tRial of neoADjuVant sAsanlimab and stereotaCtiC body radIatioN thErapy as an in situ vaccine for cisplatin-ineligible Muscle Invasive Bladder Cancer (RAD VACCINE MIBC)
Satkunasivam, R. (PI), Butler, E. B. (Key Personnel), Chan, K. S. (Key Personnel), Chen, S.-H. (Key Personnel), Esnaola, N. F. (Key Personnel), Farach, A. M. (Key Personnel), Teh, B. S. (Key Personnel) & Zhang, J. (Key Personnel)
1/20/22 → …
Project: Clinical Trial
-
Nanotechnology-based targeting of breast cancer liver metastases
Godin, B. (PI), Chen, S.-H. (Key Personnel), Niravath, P. A. (Key Personnel), Rosato, R. R. (Key Personnel) & Xu, S. (Key Personnel)
3/1/21 → 2/28/25
Project: Federal Funding Agencies
-
Mechanism of Intratumoral Transport of Particulate Drugs
Chen, S.-H. (PI)
6/15/18 → 8/31/25
Project: Federal Funding Agencies
-
Modulation of tumor inflammatory factor for immune therapy
Chen, S.-H. (PI) & Pan, P.-Y. (Project Director)
9/22/17 → 8/31/25
Project: Federal Funding Agencies
-
Not started
Neoadjuvant Atezolizumab in Patients With Non-Metastatic Resectable High-Risk Cutaneous Melanoma
Esnaola, N. F. (PI), Allenson, K. C. (Key Personnel), Chen, S.-H. (Key Personnel), Kain, J. J. (Key Personnel) & Mohyuddin, N. G. (Key Personnel)
Project: Clinical Trial
-
Finished
-
Chen - U of H - LRA-Celgene Accelerator Awards - Urinomics as a Guide to the Renal Immune Landscape in SLE
Chen, S.-H. (PI)
12/1/20 → 11/30/22
Project: Non Profit
-
Transforming triple negative breast cancer treatment through intratumoral immunotherapy via nanofluidic drug eluting seed
Chen, S.-H. (PI) & Chang, J. C. (Key Personnel)
8/1/20 → 7/31/24
Project: Federal Funding Agencies
-
Impact of WTC Dust on Immune Functions and Prostate Cancer Promotion
Chen, S.-H. (PI)
9/1/17 → 8/31/21
Project: Federal Funding Agencies
-
Intervention of Immune Tolerance by Small Molecules
Chen, S.-H. (PI) & Pan, P.-Y. (Key Personnel)
8/1/17 → 7/31/22
Project: Federal Funding Agencies
-
LILRB modulates tumor microenvironment and promotes tumor progression
Chen, S.-H. (PI) & Pan, P.-Y. (Key Personnel)
4/1/16 → 11/30/24
Project: Federal Funding Agencies